One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Corteva logo
Corteva CTVA
$ 12.72 -1.47%
report update icon

Quarterly report 2026-Q2
added 07-31-2026

Corteva Financial Ratios 2025-2011 | CTVA

Brief overview of Corteva's multiples and efficiency

The review covers five available annual periods spanning 2021 to 2025.

Market valuation is represented by P/E 46.16x (median 46.16x), EV/EBITDA 38.22x (median 34.52x), P/S 2.9x (median 2.6x). The combined ratio level is close to the company's five-year norm at a +10.6% deviation. No clear premium or discount is visible.

At the current P/E, inverse earnings yield is 2.2%, a useful bridge between price and business earnings.

The latest available business-quality ratios are ROE 4.5%, ROA 2.6%. Profitability sends a weak positive signal and leaves the business sensitive to cost or demand pressure.

Current PEG of 19.66x points to a premium over forecast earnings momentum.

The cash cycle lengthened by 19.9 days to 179.3 days. Operations require more funding.

Overall picture

Corteva trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.

Annual Financial Ratios Corteva

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

46.2 49.0 51.3 39.6 19.7 42.7 -21.7 - - - - - - - -

P/S

2.9 2.6 2.2 2.6 2.2 2.0 1.5 - - - - - - - -

EPS

1.6 1.3 1.0 1.6 2.4 0.9 -1.3 -6.8 - - - - - - -

EV (Enterprise Value)

46 B 41.4 B 35.1 B 42.2 B 30.3 B 25.6 B 19.1 B 19.1 B - - - - - - -

EBITDA per Share

1.77 1.77 1.71 1.7 1.71 1.58 2.14 - - - - - - - -

EV/EBITDA

38.2 33.7 29.0 34.5 57.8 18.0 19.1 - - - - - - - -

PEG

19.66 -16.99 - - - 0.26 -0.28 - - - - - - - -

P/B

1.2 1.1 0.9 1.1 0.8 0.7 0.5 - - - - - - - -

P/CF

14.8 20.7 21.3 52.1 12.7 14.1 19.5 - - - - - - - -

ROE %

4.53 3.81 2.94 4.53 6.86 2.72 -3.91 - - - - - - - -

ROA %

2.55 2.22 1.71 2.69 4.15 1.60 -2.26 - - - - - - - -

DSO

126.3 120.5 118.5 109.9 113.5 134.2 72.9 - - - - - - - -

DIO

220.8 236.2 252.2 209.7 199.2 212.7 107.1 - - - - - - - -

DPO

167.9 159.3 168.8 157.8 153.2 157.0 78.8 - - - - - - - -

Operating Cycle

347.2 356.7 370.8 319.6 312.7 346.9 180.0 - - - - - - - -

Cash Conversion Cycle

179.3 197.3 202.0 161.8 159.4 189.9 101.2 - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Corteva

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

1.73 1.07 -0.47 1.92 0.95 - -0.76 1.51 0.6 - -0.45 1 0.84 - -0.46 1.34 0.78 - 0.04 1.31 0.81 0.13 -0.52 1.01 0.36 -0.06 -0.66 -0.81 0.22 -1.43 -6.83 0.92 -0.6 1.58 - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

0.95 0.44 0.24 0.44 0.43 - 0.25 0.45 0.44 - 0.25 0.24 0.4 - 0.25 0.25 0.25 - 0.25 0.24 0.25 - 0.22 0.4 0.38 - 0.3 0.3 0.34 - 0.29 0.32 - 0.23 - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

11.37 9.44 4.37 9.82 6.44 3.76 2.48 7.32 5.47 3.77 2.44 7.47 6.93 4.61 4.73 9.86 8.54 6.35 6.52 4.82 4.08 2.74 2.49 2.04 -3.52 -3.95 -4.57 -9.40 -5.97 -6.79 -4.60 0.93 -0.15 1.49 - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

6.86 5.62 2.69 5.98 3.80 2.25 1.51 4.37 3.14 2.18 1.36 4.48 4.19 2.88 2.96 6.12 5.16 3.83 3.93 2.94 2.38 1.60 1.45 1.21 -2.01 -2.26 -2.70 -6.25 -4.18 -4.67 -4.71 0.64 -0.11 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

127.2 156.9 286.8 119.9 144.3 - 279.8 115.9 136.0 - 256.1 125.5 134.3 - 217.2 103.8 119.8 - 242.7 34431.7 25458.8 140.2 40863.4 49944.2 26498.0 169.1 38802.3 29672.3 30762.7 170.5 39997.9 20519.8 9017.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

161.9 202.2 267.1 147.0 205.8 - 308.1 173.2 234.1 - 331.2 177.6 220.6 - 233.1 125.9 170.3 - 233.0 119.2 173.5 210.9 343.5 157.5 199.3 233.3 340.4 150.7 213.4 239.4 326.3 157.4 122.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

136.7 164.0 226.6 120.3 154.8 - 205.6 108.0 141.1 - 195.6 106.7 145.8 - 187.1 99.6 130.8 - 192.8 93.5 126.6 156.2 254.3 116.6 147.1 171.7 250.4 110.9 154.8 171.2 233.4 108.7 82.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - 554.0 266.9 350.1 - 587.9 289.0 370.1 - 587.2 303.2 354.9 - 450.3 229.7 290.1 - 475.7 34550.8 25632.3 351.1 41206.9 50101.6 26697.3 402.4 39142.7 29823.0 30976.1 409.9 40324.2 20677.2 9140.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - 327.4 146.6 195.3 - 382.3 181.1 229.0 - 391.6 196.5 209.1 - 263.1 130.1 159.3 - 282.9 34457.3 25505.7 194.9 40952.6 49985.0 26550.2 230.8 38892.3 29712.2 30821.3 238.7 40090.8 20568.6 9057.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Corteva, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Agricultural inputs industry

Issuer Price % 24h Market Cap Country
Акрон Акрон
AKRN
- - - russiaRussia
ФосАгро ФосАгро
PHOR
- - - russiaRussia
ICL Group Ltd ICL Group Ltd
ICL
$ 4.77 -2.05 % $ 6.16 B israelIsrael
American Vanguard Corporation American Vanguard Corporation
AVD
$ 1.06 -0.47 % $ 30.1 M usaUSA
CF Industries Holdings CF Industries Holdings
CF
$ 116.3 -1.35 % $ 18.9 B usaUSA
FMC Corporation FMC Corporation
FMC
$ 5.03 -5.27 % $ 630 M usaUSA
Marrone Bio Innovations Marrone Bio Innovations
MBII
- -5.9 % $ 180 M usaUSA
Yield10 Bioscience Yield10 Bioscience
YTEN
- 15.32 % $ 46.6 M usaUSA
Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp.
BIOX
$ 0.24 -2.74 % $ 15.2 M argentinaArgentina
The Mosaic Company The Mosaic Company
MOS
$ 17.68 -0.98 % $ 5.61 B usaUSA
Arcadia Biosciences Arcadia Biosciences
RKDA
$ 0.16 2.94 % $ 219 K usaUSA
Origin Agritech Limited Origin Agritech Limited
SEED
$ 0.93 0.49 % $ 6.97 M chinaChina
The Scotts Miracle-Gro Company The Scotts Miracle-Gro Company
SMG
$ 55.93 0.09 % $ 3.22 B usaUSA
CVR Partners, LP CVR Partners, LP
UAN
$ 127.08 -0.27 % $ 1.34 B usaUSA
Intrepid Potash Intrepid Potash
IPI
$ 31.2 -2.13 % $ 406 M usaUSA
Nutrien Ltd. Nutrien Ltd.
NTR
$ 68.12 -1.3 % $ 33.1 B canadaCanada
China Green Agriculture China Green Agriculture
CGA
- 0.51 % $ 27.6 M chinaChina